Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT05156931
  4. Details
NCT05156931 Clinical Trial

Exploration of Patient Self-medication Practices During and After Cancer in France

Cancer Clinical Trial

— CASEME  

Official title:
Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05156931
Other study ID # RNI 2021 BALAYSSAC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 14, 2021
Est. completion date April 30, 2022

Study information
Verified date December 2021
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire

Description:

Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.

Recruitment information / eligibility
Status Completed
Enrollment 681
Est. completion date April 30, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Past or active cancer Exclusion Criteria: - Speaking French - Not living in France

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France CHU Clermont-Ferrand Clermont-Ferrand

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Self-medication declaration of a practice of self-medication day 1
Secondary Class of products used in self-medication non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements day 1
Secondary Indication for self-medication For treatment of side-effects, improvements in anti-cancer effects day 1
Secondary Origin of self-medication products pharmacy, market, internet, other day 1
Secondary Perception of adverse effects and drug-drug interaction related to self medication yes / no day 1
Secondary QLQ-C30 questionnaire Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties day 1
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients